Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYR-322 add-on to pioglitazone in type 2 diabetes mellitus
jRCT2080220568Phase 3
- Sponsor
- Takeda
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of alogliptin in type 2 diabetes mellitus (T2DM), sponsored by Takeda.
02
Drugs
alogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080220568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220568.